Our study implicated that the blockade of ERK could synergistically enhance the inhibitory effect of 4-HPPP on the growth of Ha22T, suggesting that targeting ERK pathways may be a way to sensitize HCC cells such as Ha22T toward 4-HPPP treatment. This evidence concerns the gene MAPK1 and hepatocellular carcinoma.